- Trials with a EudraCT protocol (81)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
81 result(s) found for: Diuresis.
Displaying page 1 of 5.
EudraCT Number: 2007-000702-71 | Sponsor Protocol Number: PreSpiDi2006-01 | Start Date*: 2007-07-13 | ||||||||||||||||
Sponsor Name:Alysis Zorggroep | ||||||||||||||||||
Full Title: The effect of intravenous fluid preload on diuresis during spinal anesthesia-induced detrusor blockade | ||||||||||||||||||
Medical condition: Diuresis during spinal anesthesia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002546-49 | Sponsor Protocol Number: SCP-01-001 | Start Date*: 2014-10-03 |
Sponsor Name:scPharmaceuticals Inc | ||
Full Title: A single center, randomized, open-label, cross-over exploratory study to evaluate the pharmacodynamic and pharmacokinetic response to a subcutaneous administration or oral administration of furosem... | ||
Medical condition: Fluid overload in heart failure | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002852-17 | Sponsor Protocol Number: SSH-IC | Start Date*: 2020-06-02 | |||||||||||
Sponsor Name:Marta Cobo Marcos | |||||||||||||
Full Title: Efficacy and Safety of Intravenous Furosemide administered with Hypertonic Saline Solution at the Heart Failure Day Hospital. SSH-IC study | |||||||||||||
Medical condition: Decompensated Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004446-42 | Sponsor Protocol Number: AIR | Start Date*: 2014-02-09 |
Sponsor Name:Skåne University Hospital | ||
Full Title: THE IMPORTANCE OF ALBUMIN INFUSION RATE FOR PLASMA VOLUME EXPANSION FOLLOWING MAJOR ABDOMINAL SURGERY | ||
Medical condition: Post operative patients who have been subjected to either a non-emergant Whipple operation or major gynecological cancer surgery ( including resection of ovaries, uterus, adnexa, oment and lymph ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003589-25 | Sponsor Protocol Number: Levo-AKI | Start Date*: 2014-11-11 |
Sponsor Name:Sahlgrenska Universitetssjukhuset/Sahlgrenska | ||
Full Title: The effect of levosimendan, on renal blood flow, function and oxygen uptake during acute renal failure after cardiac surgery | ||
Medical condition: Acute kidney injury postoperatively in connection with heart surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004801-11 | Sponsor Protocol Number: 04-081 | Start Date*: 2005-02-14 |
Sponsor Name:Zealand Pharma A/S | ||
Full Title: A Phase II, Multicenter, Double-Blind, Efficacy, Safety, and Tolerability Study of ZP120 Administered as Short Term I.V. Infusion as Add-On Therapy in Patients with Subacute Decompensated Chronic H... | ||
Medical condition: Subacute decompensated chronic heart failure NYHA Class III-IV | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-005446-15 | Sponsor Protocol Number: 202100617 | Start Date*: 2022-06-30 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: A Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Severe Chronic Kidney Disease | ||
Medical condition: Combined endpoint of all-cause mortality, kidney failure, and hospitalization for heart failure in the overall study population | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003214-41 | Sponsor Protocol Number: NEF-DIU-2013 | Start Date*: 2013-11-11 | |||||||||||
Sponsor Name:Fundació Parc Taulí | |||||||||||||
Full Title: Single center randomized clinical study to compare the efficacy of diuretics in patients in hemodialysis with residual renal function | |||||||||||||
Medical condition: Chronic renal disease stage V in hemodialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003851-31 | Sponsor Protocol Number: 000233 | Start Date*: 2017-08-24 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A Randomised, Double-blind, Placebo-controlled, Response-adaptive Dose-finding Trial Investigating the Efficacy, Safety and Tolerability of Oral Doses of FE 201836, with Desmopressin Orally Disinte... | |||||||||||||
Medical condition: Nocturia due to Nocturnal Polyuria | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) HU (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003461-96 | Sponsor Protocol Number: AGO/2017/006 | Start Date*: 2017-12-21 |
Sponsor Name:Ghent University Hospital | ||
Full Title: PSMA-PET/CT for prostate cancer | ||
Medical condition: prostate cancer (and metastases) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001852-36 | Sponsor Protocol Number: CLOROTIC | Start Date*: 2014-01-02 |
Sponsor Name:Sociedad Española de Medicina Interna | ||
Full Title: Randomized, double blinded, multicenter study, to asses Safety and Efficacy of the Combination of Loop With Thiazide-type Diuretics vs Loop diuretics with placebo in Patients With Decompensated Hea... | ||
Medical condition: Security and efficacy of Hidroclorothiazide plus Loop Diuretics in patients with descompensated heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002204-38 | Sponsor Protocol Number: NDI-2020 | Start Date*: 2020-11-24 | |||||||||||
Sponsor Name:Claus Bistrup | |||||||||||||
Full Title: Treatment of congenital nephrogenic diabetes insipidus with fluconazole, an antifungal medication | |||||||||||||
Medical condition: Nephrogenic diabetes insipidus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001846-24 | Sponsor Protocol Number: 1 | Start Date*: 2016-06-29 |
Sponsor Name:Antwerp University Hospital | ||
Full Title: Metabolism of Isotonic versus Hypotonic Maintenance Solutions in fasting healthy Adults (MIHMoSA), a Single-Blind Randomized Crossover Trial | ||
Medical condition: Healthy adult volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004560-29 | Sponsor Protocol Number: AGO/2011/010 | Start Date*: 2011-10-25 | |||||||||||
Sponsor Name:Ghent University Hospital | |||||||||||||
Full Title: Desmopressin melt therapy in nocturnal polyuria patients: pharmacodynamic study | |||||||||||||
Medical condition: Noctural polyuria | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000818-78 | Sponsor Protocol Number: 7-010-MR | Start Date*: 2008-09-25 | |||||||||||
Sponsor Name:POLICLINICO SAN DONATO IRCSS | |||||||||||||
Full Title: Efficacy of fenoldopam mesilate in controlling splanchnic ischemia during cardiopulmonary bypass | |||||||||||||
Medical condition: Patients to be submitted to cardiac surgery with expected prolonged CPB time | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023455-28 | Sponsor Protocol Number: 11102010 | Start Date*: 2010-12-15 | |||||||||||
Sponsor Name:Maija Kaukonen | |||||||||||||
Full Title: Dexmedetomidine pharmacokinetics during continuous venovenous hemofiltration and hemodiafiltration in critically ill patients | |||||||||||||
Medical condition: Intensive care patients with acute kidney injury requiring continuous renal replacement therapy with a clinical indication for sedation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001591-30 | Sponsor Protocol Number: S-20150201 | Start Date*: 2017-11-06 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: Treatment of congenital nephrogenic diabetes insipidus with a guanylate cyclase stimulator, riociguat or a phosphodiesterase type 5 inhibitor, sildenafil | |||||||||||||
Medical condition: Nephrogenic diabetes insipidus because of AVP2R-mutation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002531-27 | Sponsor Protocol Number: FE106483 CS005 | Start Date*: 2005-11-09 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: The PEACE Study: Investigating the Pharmacodynamics and Pharmacokinetics of FE 106483 Tablets in a Single Dose Study in Children with Nocturnal Enuresis. A Randomised, Double-Blind and Placebo-Cont... | |||||||||||||
Medical condition: Nocturnal Enuresis. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002353-29 | Sponsor Protocol Number: HUB-NEF-HEMOCIONA.EC | Start Date*: 2019-11-12 | ||||||||||||||||
Sponsor Name:HOSPITAL UNIVERSITARI DE BELLVITGE- IDIBELL | ||||||||||||||||||
Full Title: PHARMACOKINETICS, PHARMACODYNAMICS AND SAFETY OF APIXABAN IN PATIENTS IN HEMODAFILTRATION | ||||||||||||||||||
Medical condition: Chronic kidney disease, non-valvular atrial fibrillation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001766-11 | Sponsor Protocol Number: 2020-24 | Start Date*: 2020-04-29 |
Sponsor Name:ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE | ||
Full Title: Losartan and spironolactone treatment for COVID-19 patients with acute respiratory failure in intensive care unit | ||
Medical condition: Patients with Covid-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
